Share Price and Basic Stock Data
Last Updated: December 24, 2025, 10:32 pm
| PEG Ratio | -46.07 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Anupam Rasayan India Ltd operates in the specialty chemicals sector, focusing on providing high-quality chemical solutions. The company’s revenue trajectory has shown significant growth over the years, with sales reported at ₹1,602 Cr in FY 2023, a notable increase from ₹1,074 Cr in FY 2022. However, the revenue experienced a decline to ₹1,475 Cr in FY 2024, and further to ₹1,437 Cr in FY 2025. The trailing twelve months (TTM) revenue stood at ₹2,108 Cr, indicating a healthy average despite the recent drop. Quarterly sales figures reveal fluctuations, with the highest quarterly sales of ₹480 Cr recorded in Mar 2023, followed by a decline to ₹386 Cr in Jun 2023, and a further decrease to ₹296 Cr in Dec 2023. These trends suggest that while the company has experienced robust growth historically, recent performance indicates some volatility that investors should monitor closely.
Profitability and Efficiency Metrics
Anupam Rasayan’s profitability metrics present a mixed picture. The operating profit margin (OPM) for FY 2025 stood at 28%, which is competitive within the specialty chemicals sector. The net profit for FY 2025 was recorded at ₹160 Cr, with an earnings per share (EPS) of ₹8.49. However, the return on equity (ROE) was relatively low at 3.27%, and return on capital employed (ROCE) was reported at 8.95%, signaling room for improvement in capital efficiency. The interest coverage ratio (ICR) was noted at 3.67, indicating that the company’s earnings can sufficiently cover its interest expenses. Despite some profit fluctuations, the company has maintained a consistent OPM around 25-28% over recent years, showcasing its operational efficiency amidst rising costs.
Balance Sheet Strength and Financial Ratios
Anupam Rasayan’s balance sheet demonstrates a prudent financial structure, with total borrowings reported at ₹1,223 Cr against reserves of ₹3,083 Cr. This results in a low debt-to-equity ratio of 0.46, which is favorable compared to industry standards. The company’s current ratio of 1.42 indicates a solid liquidity position, while the quick ratio of 0.62 suggests that the company may face challenges in meeting short-term obligations without relying on inventory sales. The enterprise value (EV) stood at ₹9,804.24 Cr, translating to a market capitalization of ₹15,039 Cr, which reflects a market-to-revenue ratio of 5.83, indicating a premium valuation. However, the price-to-book value (P/BV) ratio of 2.94x suggests that the stock is valued higher than its book value, warranting careful consideration by investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Anupam Rasayan reveals a significant concentration of ownership among promoters, who hold 59.07% of the shares as of Sep 2025. This level of promoter holding could indicate strong management confidence in the company’s future prospects. Foreign institutional investors (FIIs) account for 7.63%, while domestic institutional investors (DIIs) represent a modest 1.37%. Public shareholding stands at 31.93%, reflecting a healthy distribution. The number of shareholders has declined from 73,326 in Dec 2022 to 48,785 by Sep 2025, which may raise concerns about investor sentiment. The gradual decrease in public and institutional holdings could suggest a lack of confidence or interest in the stock, emphasizing the need for the management to engage effectively with investors to bolster sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Anupam Rasayan faces both opportunities and challenges. The specialty chemicals sector remains robust, with potential for growth driven by increasing demand for chemical products. However, the company’s declining revenue trend and low ROE present significant risks. The volatility in quarterly sales and the increase in the cash conversion cycle to 715 days indicate operational inefficiencies that need to be addressed. Furthermore, external factors such as raw material costs and regulatory changes could impact profitability. Strengths include a solid balance sheet with low debt and strong operational margins. The company must enhance its capital efficiency and engage with investors to rebuild confidence. A focus on improving sales consistency and managing operational costs will be crucial for navigating future challenges.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 400 Cr. | 43.5 | 83.5/41.2 | 24.8 | 20.5 | 0.92 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 31.2 Cr. | 63.5 | 91.9/56.0 | 14.9 | 89.6 | 1.57 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 49.6 Cr. | 730 | 935/600 | 22.9 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,406 Cr. | 75.1 | 111/74.0 | 22.6 | 22.0 | 0.67 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 651 Cr. | 261 | 393/241 | 23.4 | 93.8 | 0.96 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,789.40 Cr | 727.35 | 71.42 | 183.02 | 0.44% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 344 | 393 | 392 | 480 | 386 | 392 | 296 | 401 | 254 | 294 | 390 | 500 | 486 |
| Expenses | 245 | 282 | 281 | 363 | 285 | 285 | 216 | 308 | 201 | 214 | 266 | 356 | 362 |
| Operating Profit | 99 | 111 | 111 | 117 | 101 | 107 | 79 | 93 | 53 | 80 | 124 | 144 | 124 |
| OPM % | 29% | 28% | 28% | 24% | 26% | 27% | 27% | 23% | 21% | 27% | 32% | 29% | 26% |
| Other Income | -8 | -10 | -3 | 24 | 12 | 3 | 2 | 12 | 6 | 2 | -4 | 6 | 5 |
| Interest | 12 | 16 | 14 | 20 | 18 | 20 | 25 | 26 | 22 | 27 | 32 | 31 | 36 |
| Depreciation | 16 | 18 | 18 | 19 | 19 | 20 | 20 | 21 | 21 | 22 | 29 | 31 | 31 |
| Profit before tax | 62 | 67 | 75 | 103 | 77 | 71 | 36 | 58 | 16 | 34 | 59 | 88 | 63 |
| Tax % | 32% | 29% | 28% | 29% | 32% | 31% | 28% | 30% | 25% | 10% | 9% | 29% | 23% |
| Net Profit | 42 | 48 | 54 | 73 | 52 | 49 | 26 | 40 | 12 | 31 | 54 | 63 | 48 |
| EPS in Rs | 3.96 | 4.15 | 4.00 | 5.28 | 3.59 | 3.78 | 1.68 | 2.82 | 0.36 | 1.52 | 2.56 | 4.05 | 3.10 |
Last Updated: August 19, 2025, 11:40 pm
Below is a detailed analysis of the quarterly data for Anupam Rasayan India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 486.00 Cr.. The value appears to be declining and may need further review. It has decreased from 500.00 Cr. (Mar 2025) to 486.00 Cr., marking a decrease of 14.00 Cr..
- For Expenses, as of Jun 2025, the value is 362.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 356.00 Cr. (Mar 2025) to 362.00 Cr., marking an increase of 6.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 124.00 Cr.. The value appears to be declining and may need further review. It has decreased from 144.00 Cr. (Mar 2025) to 124.00 Cr., marking a decrease of 20.00 Cr..
- For OPM %, as of Jun 2025, the value is 26.00%. The value appears to be declining and may need further review. It has decreased from 29.00% (Mar 2025) to 26.00%, marking a decrease of 3.00%.
- For Other Income, as of Jun 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2025) to 5.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 36.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 31.00 Cr. (Mar 2025) to 36.00 Cr., marking an increase of 5.00 Cr..
- For Depreciation, as of Jun 2025, the value is 31.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 31.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 63.00 Cr.. The value appears to be declining and may need further review. It has decreased from 88.00 Cr. (Mar 2025) to 63.00 Cr., marking a decrease of 25.00 Cr..
- For Tax %, as of Jun 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 29.00% (Mar 2025) to 23.00%, marking a decrease of 6.00%.
- For Net Profit, as of Jun 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 63.00 Cr. (Mar 2025) to 48.00 Cr., marking a decrease of 15.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.10. The value appears to be declining and may need further review. It has decreased from 4.05 (Mar 2025) to 3.10, marking a decrease of 0.95.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:13 am
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 502 | 529 | 811 | 1,074 | 1,602 | 1,475 | 1,437 | 2,108 |
| Expenses | 408 | 394 | 617 | 769 | 1,171 | 1,094 | 1,036 | 1,579 |
| Operating Profit | 93 | 135 | 194 | 305 | 431 | 381 | 401 | 529 |
| OPM % | 19% | 25% | 24% | 28% | 27% | 26% | 28% | 25% |
| Other Income | 19 | 11 | 26 | 8 | 10 | 30 | 11 | 15 |
| Interest | 24 | 45 | 69 | 31 | 63 | 89 | 112 | 135 |
| Depreciation | 23 | 29 | 52 | 60 | 71 | 80 | 102 | 123 |
| Profit before tax | 66 | 72 | 100 | 222 | 308 | 242 | 198 | 286 |
| Tax % | 24% | 26% | 30% | 31% | 30% | 31% | 19% | |
| Net Profit | 49 | 53 | 70 | 152 | 217 | 167 | 160 | 223 |
| EPS in Rs | 9.85 | 10.64 | 7.04 | 15.18 | 16.84 | 11.72 | 8.49 | 13.61 |
| Dividend Payout % | 0% | 0% | 7% | 7% | 15% | 11% | 9% |
YoY Net Profit Growth
| Year | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 8.16% | 32.08% | 117.14% | 42.76% | -23.04% | -4.19% |
| Change in YoY Net Profit Growth (%) | 0.00% | 23.91% | 85.07% | -74.38% | -65.80% | 18.85% |
Anupam Rasayan India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 10% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | -15% |
| TTM: | 31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 13% |
| 1 Year: | 44% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | 5% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 2:21 pm
Balance Sheet
Last Updated: December 4, 2025, 2:23 am
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 50 | 50 | 100 | 100 | 107 | 110 | 110 | 114 |
| Reserves | 432 | 515 | 1,473 | 1,627 | 2,265 | 2,651 | 2,740 | 3,083 |
| Borrowings | 694 | 847 | 423 | 836 | 822 | 1,069 | 1,373 | 1,223 |
| Other Liabilities | 146 | 252 | 301 | 327 | 584 | 772 | 1,045 | 1,230 |
| Total Liabilities | 1,323 | 1,664 | 2,298 | 2,891 | 3,778 | 4,602 | 5,269 | 5,650 |
| Fixed Assets | 681 | 977 | 1,115 | 1,202 | 1,417 | 1,501 | 2,185 | 2,422 |
| CWIP | 191 | 101 | 43 | 44 | 120 | 609 | 216 | 58 |
| Investments | 0 | 0 | 0 | 149 | 67 | 67 | 9 | 9 |
| Other Assets | 451 | 586 | 1,140 | 1,496 | 2,173 | 2,424 | 2,860 | 3,161 |
| Total Assets | 1,323 | 1,664 | 2,298 | 2,891 | 3,778 | 4,602 | 5,269 | 5,650 |
Below is a detailed analysis of the balance sheet data for Anupam Rasayan India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 114.00 Cr.. The value appears strong and on an upward trend. It has increased from 110.00 Cr. (Mar 2025) to 114.00 Cr., marking an increase of 4.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,083.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,740.00 Cr. (Mar 2025) to 3,083.00 Cr., marking an increase of 343.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,223.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,373.00 Cr. (Mar 2025) to 1,223.00 Cr., marking a decrease of 150.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,230.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,045.00 Cr. (Mar 2025) to 1,230.00 Cr., marking an increase of 185.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 5,650.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,269.00 Cr. (Mar 2025) to 5,650.00 Cr., marking an increase of 381.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2,422.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,185.00 Cr. (Mar 2025) to 2,422.00 Cr., marking an increase of 237.00 Cr..
- For CWIP, as of Sep 2025, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 216.00 Cr. (Mar 2025) to 58.00 Cr., marking a decrease of 158.00 Cr..
- For Investments, as of Sep 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00 Cr..
- For Other Assets, as of Sep 2025, the value is 3,161.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,860.00 Cr. (Mar 2025) to 3,161.00 Cr., marking an increase of 301.00 Cr..
- For Total Assets, as of Sep 2025, the value is 5,650.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,269.00 Cr. (Mar 2025) to 5,650.00 Cr., marking an increase of 381.00 Cr..
Notably, the Reserves (3,083.00 Cr.) exceed the Borrowings (1,223.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -601.00 | -712.00 | -229.00 | -531.00 | -391.00 | 380.00 | 400.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 88 | 89 | 92 | 95 | 95 | 143 | 186 |
| Inventory Days | 277 | 515 | 530 | 852 | 483 | 627 | 876 |
| Days Payable | 105 | 226 | 215 | 225 | 167 | 247 | 348 |
| Cash Conversion Cycle | 260 | 379 | 408 | 722 | 410 | 524 | 715 |
| Working Capital Days | 56 | 21 | 168 | 218 | 153 | 138 | 160 |
| ROCE % | 9% | 10% | 11% | 13% | 9% | 7% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Quant Small Cap Fund | 437,155 | 0.15 | 46.96 | 2,086,516 | 2025-10-30 05:20:15 | -79.05% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 14.56 | 15.48 | 20.91 | 15.22 | 8.56 |
| Diluted EPS (Rs.) | 14.56 | 15.46 | 20.86 | 15.18 | 8.56 |
| Cash EPS (Rs.) | 23.86 | 22.51 | 26.66 | 21.11 | 12.20 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 259.28 | 251.49 | 233.38 | 172.26 | 157.46 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 259.28 | 251.49 | 233.38 | 172.26 | 157.46 |
| Revenue From Operations / Share (Rs.) | 130.72 | 134.36 | 149.06 | 106.34 | 81.15 |
| PBDIT / Share (Rs.) | 37.51 | 37.43 | 40.94 | 31.14 | 22.04 |
| PBIT / Share (Rs.) | 28.20 | 30.17 | 34.32 | 25.14 | 16.87 |
| PBT / Share (Rs.) | 18.00 | 22.02 | 28.49 | 22.07 | 10.01 |
| Net Profit / Share (Rs.) | 14.55 | 15.25 | 20.04 | 15.12 | 7.04 |
| NP After MI And SOA / Share (Rs.) | 8.49 | 11.71 | 16.83 | 15.18 | 7.04 |
| PBDIT Margin (%) | 28.69 | 27.85 | 27.46 | 29.28 | 27.15 |
| PBIT Margin (%) | 21.57 | 22.45 | 23.02 | 23.64 | 20.78 |
| PBT Margin (%) | 13.76 | 16.39 | 19.11 | 20.75 | 12.33 |
| Net Profit Margin (%) | 11.13 | 11.35 | 13.44 | 14.21 | 8.66 |
| NP After MI And SOA Margin (%) | 6.49 | 8.71 | 11.28 | 14.27 | 8.66 |
| Return on Networth / Equity (%) | 3.27 | 4.65 | 7.62 | 8.81 | 4.46 |
| Return on Capital Employeed (%) | 8.95 | 10.07 | 12.43 | 10.97 | 8.97 |
| Return On Assets (%) | 1.77 | 2.79 | 4.78 | 5.26 | 3.05 |
| Long Term Debt / Equity (X) | 0.06 | 0.07 | 0.14 | 0.28 | 0.15 |
| Total Debt / Equity (X) | 0.46 | 0.36 | 0.33 | 0.46 | 0.24 |
| Asset Turnover Ratio (%) | 0.29 | 0.35 | 0.48 | 0.41 | 0.40 |
| Current Ratio (X) | 1.42 | 1.69 | 2.60 | 2.43 | 2.59 |
| Quick Ratio (X) | 0.62 | 0.89 | 1.46 | 0.98 | 1.42 |
| Inventory Turnover Ratio (X) | 1.15 | 1.48 | 0.85 | 1.02 | 1.19 |
| Dividend Payout Ratio (NP) (%) | 8.82 | 16.71 | 5.78 | 3.28 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 4.21 | 10.32 | 4.15 | 2.35 | 0.00 |
| Earning Retention Ratio (%) | 91.18 | 83.29 | 94.22 | 96.72 | 0.00 |
| Cash Earning Retention Ratio (%) | 95.79 | 89.68 | 95.85 | 97.65 | 0.00 |
| Interest Coverage Ratio (X) | 3.67 | 4.59 | 7.02 | 10.13 | 3.21 |
| Interest Coverage Ratio (Post Tax) (X) | 2.43 | 2.87 | 4.44 | 5.92 | 2.03 |
| Enterprise Value (Cr.) | 9804.24 | 10438.77 | 9646.44 | 8830.95 | 4991.83 |
| EV / Net Operating Revenue (X) | 6.82 | 7.08 | 6.02 | 8.28 | 6.16 |
| EV / EBITDA (X) | 23.78 | 25.40 | 21.93 | 28.29 | 22.67 |
| MarketCap / Net Operating Revenue (X) | 5.83 | 6.47 | 5.80 | 7.73 | 6.04 |
| Retention Ratios (%) | 91.17 | 83.28 | 94.21 | 96.71 | 0.00 |
| Price / BV (X) | 2.94 | 3.45 | 3.91 | 4.77 | 3.11 |
| Price / Net Operating Revenue (X) | 5.83 | 6.47 | 5.80 | 7.73 | 6.04 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Anupam Rasayan India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 14.56. This value is within the healthy range. It has decreased from 15.48 (Mar 24) to 14.56, marking a decrease of 0.92.
- For Diluted EPS (Rs.), as of Mar 25, the value is 14.56. This value is within the healthy range. It has decreased from 15.46 (Mar 24) to 14.56, marking a decrease of 0.90.
- For Cash EPS (Rs.), as of Mar 25, the value is 23.86. This value is within the healthy range. It has increased from 22.51 (Mar 24) to 23.86, marking an increase of 1.35.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 259.28. It has increased from 251.49 (Mar 24) to 259.28, marking an increase of 7.79.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 259.28. It has increased from 251.49 (Mar 24) to 259.28, marking an increase of 7.79.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 130.72. It has decreased from 134.36 (Mar 24) to 130.72, marking a decrease of 3.64.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 37.51. This value is within the healthy range. It has increased from 37.43 (Mar 24) to 37.51, marking an increase of 0.08.
- For PBIT / Share (Rs.), as of Mar 25, the value is 28.20. This value is within the healthy range. It has decreased from 30.17 (Mar 24) to 28.20, marking a decrease of 1.97.
- For PBT / Share (Rs.), as of Mar 25, the value is 18.00. This value is within the healthy range. It has decreased from 22.02 (Mar 24) to 18.00, marking a decrease of 4.02.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 14.55. This value is within the healthy range. It has decreased from 15.25 (Mar 24) to 14.55, marking a decrease of 0.70.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.49. This value is within the healthy range. It has decreased from 11.71 (Mar 24) to 8.49, marking a decrease of 3.22.
- For PBDIT Margin (%), as of Mar 25, the value is 28.69. This value is within the healthy range. It has increased from 27.85 (Mar 24) to 28.69, marking an increase of 0.84.
- For PBIT Margin (%), as of Mar 25, the value is 21.57. This value exceeds the healthy maximum of 20. It has decreased from 22.45 (Mar 24) to 21.57, marking a decrease of 0.88.
- For PBT Margin (%), as of Mar 25, the value is 13.76. This value is within the healthy range. It has decreased from 16.39 (Mar 24) to 13.76, marking a decrease of 2.63.
- For Net Profit Margin (%), as of Mar 25, the value is 11.13. This value exceeds the healthy maximum of 10. It has decreased from 11.35 (Mar 24) to 11.13, marking a decrease of 0.22.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.49. This value is below the healthy minimum of 8. It has decreased from 8.71 (Mar 24) to 6.49, marking a decrease of 2.22.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.27. This value is below the healthy minimum of 15. It has decreased from 4.65 (Mar 24) to 3.27, marking a decrease of 1.38.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.95. This value is below the healthy minimum of 10. It has decreased from 10.07 (Mar 24) to 8.95, marking a decrease of 1.12.
- For Return On Assets (%), as of Mar 25, the value is 1.77. This value is below the healthy minimum of 5. It has decreased from 2.79 (Mar 24) to 1.77, marking a decrease of 1.02.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.07 (Mar 24) to 0.06, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.46. This value is within the healthy range. It has increased from 0.36 (Mar 24) to 0.46, marking an increase of 0.10.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.29. It has decreased from 0.35 (Mar 24) to 0.29, marking a decrease of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 1.5. It has decreased from 1.69 (Mar 24) to 1.42, marking a decrease of 0.27.
- For Quick Ratio (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.89 (Mar 24) to 0.62, marking a decrease of 0.27.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 4. It has decreased from 1.48 (Mar 24) to 1.15, marking a decrease of 0.33.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 8.82. This value is below the healthy minimum of 20. It has decreased from 16.71 (Mar 24) to 8.82, marking a decrease of 7.89.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 4.21. This value is below the healthy minimum of 20. It has decreased from 10.32 (Mar 24) to 4.21, marking a decrease of 6.11.
- For Earning Retention Ratio (%), as of Mar 25, the value is 91.18. This value exceeds the healthy maximum of 70. It has increased from 83.29 (Mar 24) to 91.18, marking an increase of 7.89.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 95.79. This value exceeds the healthy maximum of 70. It has increased from 89.68 (Mar 24) to 95.79, marking an increase of 6.11.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.67. This value is within the healthy range. It has decreased from 4.59 (Mar 24) to 3.67, marking a decrease of 0.92.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.43. This value is below the healthy minimum of 3. It has decreased from 2.87 (Mar 24) to 2.43, marking a decrease of 0.44.
- For Enterprise Value (Cr.), as of Mar 25, the value is 9,804.24. It has decreased from 10,438.77 (Mar 24) to 9,804.24, marking a decrease of 634.53.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.82. This value exceeds the healthy maximum of 3. It has decreased from 7.08 (Mar 24) to 6.82, marking a decrease of 0.26.
- For EV / EBITDA (X), as of Mar 25, the value is 23.78. This value exceeds the healthy maximum of 15. It has decreased from 25.40 (Mar 24) to 23.78, marking a decrease of 1.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.83. This value exceeds the healthy maximum of 3. It has decreased from 6.47 (Mar 24) to 5.83, marking a decrease of 0.64.
- For Retention Ratios (%), as of Mar 25, the value is 91.17. This value exceeds the healthy maximum of 70. It has increased from 83.28 (Mar 24) to 91.17, marking an increase of 7.89.
- For Price / BV (X), as of Mar 25, the value is 2.94. This value is within the healthy range. It has decreased from 3.45 (Mar 24) to 2.94, marking a decrease of 0.51.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.83. This value exceeds the healthy maximum of 3. It has decreased from 6.47 (Mar 24) to 5.83, marking a decrease of 0.64.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Anupam Rasayan India Ltd:
- Net Profit Margin: 11.13%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.95% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.27% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.43
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 99.5 (Industry average Stock P/E: 71.42)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.46
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 11.13%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | 1101 to 1107, 11th Floor, Icon Rio, Behind Icon Business Centre, Surat Gujarat 395007 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Kiran Chhotubhai Patel | Chairman & Non-Exe.Director |
| Mrs. Mona Anandbhai Desai | Vice Chairman & Whole Time Dir |
| Mr. Anand Sureshbhai Desai | Managing Director |
| Dr. Anuj Hemantbhai Thakar | Whole Time Director |
| Mr. Ketan Paragji Desai | Independent Director |
| Dr. Madhuri Ajit Sawant | Independent Director |
| Mr. Anand Rajeshwarrao Chatorikar | Independent Director |
FAQ
What is the intrinsic value of Anupam Rasayan India Ltd?
Anupam Rasayan India Ltd's intrinsic value (as of 25 December 2025) is 743.05 which is 43.75% lower the current market price of 1,321.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 15,039 Cr. market cap, FY2025-2026 high/low of 1,346/601, reserves of ₹3,083 Cr, and liabilities of 5,650 Cr.
What is the Market Cap of Anupam Rasayan India Ltd?
The Market Cap of Anupam Rasayan India Ltd is 15,039 Cr..
What is the current Stock Price of Anupam Rasayan India Ltd as on 25 December 2025?
The current stock price of Anupam Rasayan India Ltd as on 25 December 2025 is 1,321.
What is the High / Low of Anupam Rasayan India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Anupam Rasayan India Ltd stocks is 1,346/601.
What is the Stock P/E of Anupam Rasayan India Ltd?
The Stock P/E of Anupam Rasayan India Ltd is 99.5.
What is the Book Value of Anupam Rasayan India Ltd?
The Book Value of Anupam Rasayan India Ltd is 281.
What is the Dividend Yield of Anupam Rasayan India Ltd?
The Dividend Yield of Anupam Rasayan India Ltd is 0.06 %.
What is the ROCE of Anupam Rasayan India Ltd?
The ROCE of Anupam Rasayan India Ltd is 7.33 %.
What is the ROE of Anupam Rasayan India Ltd?
The ROE of Anupam Rasayan India Ltd is 3.32 %.
What is the Face Value of Anupam Rasayan India Ltd?
The Face Value of Anupam Rasayan India Ltd is 10.0.